Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease

NCT07596979 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.

NCT NCT07596979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07596979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease
Lead sponsor
Universidade Federal Fluminense
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 18, 2026
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), inflammation, oxidative stress